You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 10,869,928


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,869,928 protect, and when does it expire?

Patent 10,869,928 protects PEPAXTO and is included in one NDA.

This patent has sixty-four patent family members in twenty-eight countries.

Summary for Patent: 10,869,928
Title:Lyophilized preparation of cytotoxic dipeptides
Abstract: The present invention is directed to novel lyophilized pharmaceutical preparations comprising a cytotoxic dipeptides such as melphalan flufenamide and one or more excipient(s) selected from the group comprising a polysorbate; a polyethylene glycol; .beta.-cyclodextrin; ocyclodextrin; hydroxypropyl-.beta.-cyclodextrin; sulfobutylether-.beta.-cyclodextrin; lactose; benzyl alcohol; disodium succinate; propylene glycol; Cremophor EL; Dimethyl sulfoxide; D-mannitol; Trehalose; Sucrose and an amino acid. This preparation may be further formulated and is useful in cancer therapy.
Inventor(s): Spira; Jack (Tyreso, SE), Lehmann; Fredrik (Knivsta, SE)
Assignee: ONCOPEPTIDES AB (Stockholm, SE)
Application Number:16/721,639
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;

Drugs Protected by US Patent 10,869,928

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Oncopeptides Ab PEPAXTO melphalan flufenamide hydrochloride POWDER;INTRAVENOUS 214383-001 Feb 26, 2021 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,869,928

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden1150371Apr 28, 2011

International Family Members for US Patent 10,869,928

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2012247545 ⤷  Try a Trial
Brazil 112013027584 ⤷  Try a Trial
Canada 2833500 ⤷  Try a Trial
Canada 3024230 ⤷  Try a Trial
China 103547279 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.